AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 6-K

Alithya Group inc (ALYAF): Financial results for Q1 2027

Alithya Group inc (ALYAF) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Alithya reports first quarter Fiscal 2027 results Alithya retains Scotiabank as financial advisor in connection with strategic review process Q1-2027 Highlights • Revenues decreased 15.4% to $105.1 million, compared to $124.2 million for the same quarter last year. 7

Event · Earnings
Also in this documentBuyback · 5.94M

Facts are quoted from the filing text and checked against it.

Original reporting
SEC EDGAR 6-K
Published Aug 13, 2026, 11:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$ALYAF
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

Med
01

Why it matters

The earnings miss is likely to trigger a sell‑off, but the strategic review could create M&A speculation.

02

Market read

Primary earnings release for a mid‑cap Canadian tech firm; immediate relevance to TSX and investors tracking digital services sector.

03

What to watch

Potential upside from strategic alternatives (sale, merger, recapitalization) could mitigate earnings weakness.

Relevance 7/10Novelty 8/10Timing: after-hours release on Aug 13

Background

Alithya Group Inc. filed a Form 6‑K reporting its Q1 2027 results, noting a 15% revenue decline and a net loss, while launching a strategic review with Scotiabank as advisor.

Market effects

Sector

Highlights weakness in Canadian digital transformation services sector.

Regional

May weigh on TSX technology stocks.

Global

Limited to investors with exposure to Alithya or similar firms.

Counterpoint

What could challenge this read

Management emphasizes a strong pipeline and strategic review, suggesting potential upside if a transaction materializes.

Key entities

  • company
    Alithya Group Inc.

    Canadian digital transformation services provider.

  • advisor
    Scotiabank

    Financial advisor for Alithya's strategic review.

Read at source← All news

Related articles

$ALYAFMed

Alithya Group inc (ALYAF): Financial results for Q2 2027

Alithya Group inc (ALYAF) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Alithya reports second quarter Fiscal 2027 results Bookings (1) reach $108.2 million, with a Book-to-Bill Ratio (1) of 1.05 Q2-2027 Highlights • Revenues of $103.4 million, down 16.8% year-over-year. 82.6% of revenues were generated from clients which we had in the s

SEC EDGAR 6-K
$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

finance.yahoo.com
$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

finance.yahoo.com
$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

finance.yahoo.com
$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

finance.yahoo.com